Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soledad Iseas

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Translational Oncology|March 31, 2021
A clinical and molecular portrait of non-metastatic anal squamous cell carcinomaSoledad Iseas, Mariano Golubicki, Juan Robbio, et al.
The Lancet. Oncology|November 7, 2025
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trialStefano Kim, Jihane Boustani, Soledad Iseas, et al.
Clinical Colorectal Cancer|May 12, 2020
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV InfectionMarcos Pedro Guedes Camandaroba, Soledad Iseas, Caroline Oliveira, et al.
Cancers|August 14, 2020
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerJuan M Sendoya, Soledad Iseas, Mariana Coraglio, et al.
Oncotarget|January 12, 2022
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, et al.
JCI Insight|August 26, 2020
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndromeMariano Golubicki, Laia Bonjoch, José G Acuña-Ochoa, et al.
Frontiers in Oncology|January 24, 2022
Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal CancerSoledad Iseas, Juan M Sendoya, Juan Robbio, et al.
Frontiers in Oncology|April 8, 2022
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal CancerIsabella Kuniko T M Takenaka, Thais F Bartelli, Alexandre Defelicibus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait StrategyCarine El Sissy, Amos Kirilovsky, Marc Van den Eynde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait StrategyCarine El Sissy, Amos Kirilovsky, Christine Lagorce Pagès, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Translational Oncology|March 31, 2021
A clinical and molecular portrait of non-metastatic anal squamous cell carcinomaSoledad Iseas, Mariano Golubicki, Juan Robbio, et al.
The Lancet. Oncology|November 7, 2025
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trialStefano Kim, Jihane Boustani, Soledad Iseas, et al.
Clinical Colorectal Cancer|May 12, 2020
Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV InfectionMarcos Pedro Guedes Camandaroba, Soledad Iseas, Caroline Oliveira, et al.
Cancers|August 14, 2020
Pre-Existing Tumoral B Cell Infiltration and Impaired Genome Maintenance Correlate with Response to Chemoradiotherapy in Locally Advanced Rectal CancerJuan M Sendoya, Soledad Iseas, Mariana Coraglio, et al.
Oncotarget|January 12, 2022
The "Immunoscore" in rectal cancer: could we search quality beyond quantity of life?Amos Kirilovsky, Carine El Sissy, Guy Zeitoun, et al.
JCI Insight|August 26, 2020
Germline biallelic Mcm8 variants are associated with early-onset Lynch-like syndromeMariano Golubicki, Laia Bonjoch, José G Acuña-Ochoa, et al.
Frontiers in Oncology|January 24, 2022
Prognostic Impact of An Integrative Landscape of Clinical, Immune, and Molecular Features in Non-Metastatic Rectal CancerSoledad Iseas, Juan M Sendoya, Juan Robbio, et al.
Frontiers in Oncology|April 8, 2022
Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal CancerIsabella Kuniko T M Takenaka, Thais F Bartelli, Alexandre Defelicibus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2020
A Diagnostic Biopsy-Adapted Immunoscore Predicts Response to Neoadjuvant Treatment and Selects Patients with Rectal Cancer Eligible for a Watch-and-Wait StrategyCarine El Sissy, Amos Kirilovsky, Marc Van den Eynde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2023
International Validation of the Immunoscore Biopsy in Patients With Rectal Cancer Managed by a Watch-and-Wait StrategyCarine El Sissy, Amos Kirilovsky, Christine Lagorce Pagès, et al.
Pageof 2